Cost effectiveness analysis of prostate cancer screening strategies in Germany: a microsimulation study : cancer therapy and prevention
Prostate cancer (PCa) represents a significant public health challenge in Germany, with increasing incidence and economic impact. This study assessed the cost-effectiveness of 10 screening strategies: prostate-specific antigen-based risk-adaptive screening (PSA-RAS), with or without magnetic resonan...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
15 October 2025
|
| In: |
International journal of cancer
Year: 2025, Volume: 157, Issue: 8, Pages: 1662-1679 |
| ISSN: | 1097-0215 |
| DOI: | 10.1002/ijc.35513 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1002/ijc.35513 Verlag, kostenfrei, Volltext: http://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.35513 
|
| Author Notes: | Muchandifunga Trust Muchadeyi, Shuang Hao, Karla Hernandez-Villafuerte, Shah Alam Khan, Nikolaus Becker, Agne Krilaviciute, Petra Seibold, Roman Gulati, Peter Albers, Michael Schlander, Mark Clements |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1935981110 | ||
| 003 | DE-627 | ||
| 005 | 20250915125911.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250915s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ijc.35513 |2 doi | |
| 035 | |a (DE-627)1935981110 | ||
| 035 | |a (DE-599)KXP1935981110 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Muchadeyi, Muchandifunga Trust |d 1982- |e VerfasserIn |0 (DE-588)1296469840 |0 (DE-627)185293087X |4 aut | |
| 245 | 1 | 0 | |a Cost effectiveness analysis of prostate cancer screening strategies in Germany |b a microsimulation study : cancer therapy and prevention |c Muchandifunga Trust Muchadeyi, Shuang Hao, Karla Hernandez-Villafuerte, Shah Alam Khan, Nikolaus Becker, Agne Krilaviciute, Petra Seibold, Roman Gulati, Peter Albers, Michael Schlander, Mark Clements |
| 264 | 1 | |c 15 October 2025 | |
| 300 | |b Diagramme | ||
| 300 | |a 18 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Erstmals veröffentlicht: 16. Juli 2025 | ||
| 500 | |a Gesehen am 15.09.2025 | ||
| 520 | |a Prostate cancer (PCa) represents a significant public health challenge in Germany, with increasing incidence and economic impact. This study assessed the cost-effectiveness of 10 screening strategies: prostate-specific antigen-based risk-adaptive screening (PSA-RAS), with or without magnetic resonance imaging (MRI), in men starting at age 45 or 50 and stopping at 60 or 70, digital rectal examination (DRE) for ages 45-75 years, and no screening. Using a well calibrated microsimulation model (Swedish Prostata) from a statutory health insurance perspective, lifetime outcomes were evaluated, including cancer incidence, mortality, overdiagnosis, biopsies, life-years, and quality-adjusted life-years (QALYs) discounted annually at 3%. Cost and utility inputs were derived from the German diagnostic-related group schedule, fee-for-service catalogues, literature, and expert opinion. DRE-only was the least cost-effective, yielding high biopsy and overdiagnosis rates with minimal QALY gains. PSA-RAS reduced overdiagnosis and biopsy rates, with PSA-RAS (50-60 years) without MRI emerging as the most cost-efficient strategy, saving approximately €1.2 million per 100,000 men compared with no screening. Extending the PSA-RAS to 70 years improved its effectiveness in terms of QALYs. PSA-RAS (50-70) with MRI could become cost-effective at an increasing willingness to pay threshold or decreasing MRI cost. This study suggests the potential of PSA-RAS to improve PCa screening in Germany. Incorporating MRI, reducing MRI cost within the screening setting, and extending screening to 70 to align with EU recommendations could improve the cost-effectiveness of PSA-RAS with MRI. Future research should explore the integration of MRI with ancillary tests, such as 4K-score or risk calculators, to reduce MRI use and associated costs. | ||
| 650 | 4 | |a cost-effectiveness analysis | |
| 650 | 4 | |a magnetic resonance imaging | |
| 650 | 4 | |a organised screening | |
| 650 | 4 | |a prostate cancer | |
| 650 | 4 | |a prostate-specific antigen | |
| 650 | 4 | |a QALYs | |
| 700 | 1 | |a Hao, Shuang |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hernandez-Villafuerte, Karla |e VerfasserIn |4 aut | |
| 700 | 1 | |a Khan, Shah Alam |d 1988- |e VerfasserIn |0 (DE-588)1376484986 |0 (DE-627)1935981676 |4 aut | |
| 700 | 1 | |a Becker, Nikolaus |e VerfasserIn |4 aut | |
| 700 | 1 | |a Krilaviciute, Agne |e VerfasserIn |4 aut | |
| 700 | 1 | |a Seibold, Petra |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gulati, Roman |e VerfasserIn |4 aut | |
| 700 | 1 | |a Albers, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schlander, Michael |d 1959- |e VerfasserIn |0 (DE-588)1036904652 |0 (DE-627)751411957 |0 (DE-576)389587710 |4 aut | |
| 700 | 1 | |a Clements, Mark |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of cancer |d Bognor Regis : Wiley-Liss, 1966 |g 157(2025), 8 vom: Okt., Seite 1662-1679 |h Online-Ressource |w (DE-627)269532781 |w (DE-600)1474822-8 |w (DE-576)079876129 |x 1097-0215 |7 nnas |a Cost effectiveness analysis of prostate cancer screening strategies in Germany a microsimulation study : cancer therapy and prevention |
| 773 | 1 | 8 | |g volume:157 |g year:2025 |g number:8 |g month:10 |g pages:1662-1679 |g extent:18 |a Cost effectiveness analysis of prostate cancer screening strategies in Germany a microsimulation study : cancer therapy and prevention |
| 856 | 4 | 0 | |u https://doi.org/10.1002/ijc.35513 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.35513 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250915 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 1036904652 |a Schlander, Michael |m 1036904652:Schlander, Michael |p 10 | ||
| 998 | |g 1376484986 |a Khan, Shah Alam |m 1376484986:Khan, Shah Alam |d 60000 |e 60000PK1376484986 |k 0/60000/ |p 4 | ||
| 998 | |g 1296469840 |a Muchadeyi, Muchandifunga Trust |m 1296469840:Muchadeyi, Muchandifunga Trust |d 60000 |e 60000PM1296469840 |k 0/60000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1935981110 |e 4772430032 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Erstmals veröffentlicht: 16. Juli 2025","Gesehen am 15.09.2025"],"relHost":[{"disp":"Cost effectiveness analysis of prostate cancer screening strategies in Germany a microsimulation study : cancer therapy and preventionInternational journal of cancer","recId":"269532781","id":{"doi":["10.1002/(ISSN)1097-0215"],"eki":["269532781"],"zdb":["1474822-8"],"issn":["1097-0215"]},"origin":[{"publisherPlace":"Bognor Regis","dateIssuedKey":"1966","publisher":"Wiley-Liss","dateIssuedDisp":"1966-"}],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"corporate":[{"display":"International Union against Cancer","role":"isb"}],"title":[{"title_sort":"International journal of cancer","subtitle":"publication of the International Union against Cancer (UICC) = Journal international du cancer","title":"International journal of cancer"}],"titleTranslated":[{"translated":"Journal international du cancer"}],"part":{"issue":"8","year":"2025","extent":"18","text":"157(2025), 8 vom: Okt., Seite 1662-1679","volume":"157","pages":"1662-1679"},"pubHistory":["1.1966 -"],"note":["Gesehen am 28.02.08","Darin: Predictive oncology"],"titleAlt":[{"title":"Predictive oncology"}]}],"language":["eng"],"physDesc":[{"extent":"18 S.","noteIll":"Diagramme"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"family":"Muchadeyi","given":"Muchandifunga Trust","role":"aut","display":"Muchadeyi, Muchandifunga Trust"},{"role":"aut","given":"Shuang","family":"Hao","display":"Hao, Shuang"},{"family":"Hernandez-Villafuerte","given":"Karla","role":"aut","display":"Hernandez-Villafuerte, Karla"},{"display":"Khan, Shah Alam","role":"aut","given":"Shah Alam","family":"Khan"},{"given":"Nikolaus","role":"aut","family":"Becker","display":"Becker, Nikolaus"},{"role":"aut","given":"Agne","family":"Krilaviciute","display":"Krilaviciute, Agne"},{"display":"Seibold, Petra","role":"aut","given":"Petra","family":"Seibold"},{"family":"Gulati","given":"Roman","role":"aut","display":"Gulati, Roman"},{"family":"Albers","given":"Peter","role":"aut","display":"Albers, Peter"},{"family":"Schlander","given":"Michael","role":"aut","display":"Schlander, Michael"},{"role":"aut","given":"Mark","family":"Clements","display":"Clements, Mark"}],"title":[{"title_sort":"Cost effectiveness analysis of prostate cancer screening strategies in Germany","subtitle":"a microsimulation study : cancer therapy and prevention","title":"Cost effectiveness analysis of prostate cancer screening strategies in Germany"}],"name":{"displayForm":["Muchandifunga Trust Muchadeyi, Shuang Hao, Karla Hernandez-Villafuerte, Shah Alam Khan, Nikolaus Becker, Agne Krilaviciute, Petra Seibold, Roman Gulati, Peter Albers, Michael Schlander, Mark Clements"]},"recId":"1935981110","id":{"eki":["1935981110"],"doi":["10.1002/ijc.35513"]},"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"15 October 2025"}]} | ||
| SRT | |a MUCHADEYIMCOSTEFFECT1520 | ||